Dr. Gaston De Serres is an epidemiologist practitioner at the l’Institut national de santé publique du Québec and a regular researcher in the Infectious and Immune Disease Axis at the CHU de Québec-Laval University. He is a full professor in epidemiology in the Department of social and preventive medicine at Laval University where he has been teaching since 1997. He is chief physician of the scientific immunization group (SIG) of the Institut national de santé publique du Québec and an active member of the Comité sur l’immunisation du Québec (CIQ).

Dr. De Serre works on the control and prevention of infectious diseases, with a focus on diseases that are avoidable through vaccination and on respiratory diseases. His research work is on the epidemiology of diseases that are preventable through vaccination and the efficacy of vaccinations used in routine programs, and in particular, on the efficacy of the influenza vaccine.

2400, avenue d'Estimauville, 3e étage
Québec, Québec
Canada G1E 7G9
339 entries « 33 of 34 »

Bailo Diallo A, De Serres G, Béavogui AH, Lapointe C, Viens P

Home care of malaria-infected children of less than 5 years of age in a rural area of the Republic of Guinea.

Journal Article

Bull World Health Organ, 79 (1), pp. 28-32, 2001, ISSN: 0042-9686.

Abstract | Links:

De Serres G, Shadmani R, Duval B, Boulianne N, Dery P, Douville Fradet M, Rochette L, Halperin SA

Morbidity of pertussis in adolescents and adults.

Journal Article

J Infect Dis, 182 (1), pp. 174-9, 2000, ISSN: 0022-1899.

Abstract | Links:

Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G

Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes.

Journal Article

Vaccine, 18 (25), pp. 2775-8, 2000, ISSN: 0264-410X.

Abstract | Links:

De Serres G, Gay NJ, Farrington CP

Epidemiology of transmissible diseases after elimination.

Journal Article

Am J Epidemiol, 151 (11), pp. 1039-48; discussion 1049-52, 2000, ISSN: 0002-9262.

Abstract | Links:

De Serres G

An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine.

Journal Article

Can Commun Dis Rep, 26 , pp. 1-8, 2000, ISSN: 1188-4169.

| Links:

Duval B, Boulianne N, De Serres G, Laflamme N, De Wals P, Massé R, Trudeau G, Delage G, Desjardins L

Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children.

Journal Article

Vaccine, 18 (15), pp. 1467-72, 2000, ISSN: 0264-410X.

Abstract | Links:

Halperin SA, Bortolussi R, Langley JM, Eastwood BJ, De Serres G

A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection.

Journal Article

Pediatrics, 104 (4), pp. e42, 1999, ISSN: 0031-4005.

Abstract | Links:

De Serres G, Sciberras J, Naus M, Boulianne N, Duval B, Rochette L

Protection after two doses of measles vaccine is independent of interval between doses.

Journal Article

J Infect Dis, 180 (1), pp. 187-90, 1999, ISSN: 0022-1899.

Abstract | Links:

Deeks S, De Serres G, Boulianne N, Duval B, Rochette L, Déry P, Halperin S

Failure of physicians to consider the diagnosis of pertussis in children.

Journal Article

Clin Infect Dis, 28 (4), pp. 840-6, 1999, ISSN: 1058-4838.

Abstract | Links:

Rochette M, De Serres G, Duclos P, Bolduc D, Jutras P, Gamache S, Gagnon YD, Halperin SA

A single dose of an effective whole cell pertussis vaccine does not significantly increase protection in children primed with a less effective vaccine.

Journal Article

Vaccine, 17 (5), pp. 448-53, 1999, ISSN: 0264-410X.

Abstract | Links:

339 entries « 33 of 34 »
Signaler des ajouts ou des modifications

Active projects

  • (CV04 QC03) CANVAS Network - Surveillance of adverse events following immunization among children and adults immunized with the influenza vaccine, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2017-06-01 to 2022-03-31
  • (SI03 QC03) Special Immunization Clinic Network (SIC) to investigate vaccine safety issues: Optimizing the clinical management of patients with contraindication to vaccination ..., Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2019-04-01 to 2022-03-31
  • Canadian Immunization Research Network, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2014-06-01 to 2021-12-31
  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31

Recently finished projects

  • Capacité du vaccin ... à induire des niveaux protecteurs d'anticorps contre l'influenza B de la lignée Victoria chez des enfants initialement immunisés 9 ans auparavant avec des doses de vaccins contenant la lignée Yamagata (TITER III), Subvention, Ministère de la Santé et des Services sociaux, from 2019-01-15 to 2019-12-31
  • Interchangeabilité des vaccins VPH., Subvention, Ministère de la Santé et des Services sociaux, from 2011-03-29 to 2019-12-31
Data provided by the Université Laval research projects registery